Friday, March 6, 2015

The Role of Routine Clinical Pretreatment 18F-FDG PET/CT in Predicting Outcome of Colorectal Liver Metastasis

In colorectal cancer, pretreatment FDG PET/CT SUVmean less than 4.48, SUVmax less than 6.59, total lesion glycolysis less than 75.2, and metabolic tumor volume less than 4.49 cm were all associated with a longer progression free survival.  (Clin Nucl Med. 2015 Feb 4.)
Read More